Deva Holding A.S. is a topic of great relevance today, since it has aroused the interest of numerous people around the world. Since its emergence, it has generated a wide range of opinions and discussions, as well as having an impact on various areas of society. Its importance lies in the influence it has on people's daily lives, as well as its potential to generate significant changes in different aspects. In this article, we will explore in detail the various facets and repercussions of Deva Holding A.S., with the aim of providing a complete and enriching analysis of this topic that is so relevant today.
![]() | |
Company type | Pharmaceutical Company |
---|---|
BİST: DEVA | |
Industry | Healthcare |
Founded | September 22, 1958 |
Headquarters | Istanbul, Turkey |
Key people | Mr. Philipp Haas (Chairman and CEO) |
Products | Pharmaceuticals |
Revenue | US$480M (2023) |
Number of employees | 2,300 |
Website | www.deva.com.tr |
Pharmaceutical manufacturer Deva Holding A.S. is a Turkish Fortune 500 company with annual revenue of more than US$480 million and a staff of approximately 2,300 across its operations in Turkey, Germany, USA and New Zealand.[1][2][3]
Established in 1958, Deva Holding A.S. is Turkey’s second-largest pharmaceutical company and is primarily engaged in the production and distribution of pharmaceutical and veterinary products.[4][5]